Commission pour l’Éducation

Special Interest:

Reproductive Endocrinology, in particular male and female infertility, the genetics of male infertility, ovulation induction, recurrent miscarriage, assisted reproduction (IVF/ICSI), OHSS prevention and advanced gynaecological and reproductive endoscopy.

Dr. Rishma Pai is an honorary consultant Gynaecologist at the Lilavati, Jaslok and Hinduja Health Care Hospitals, Mumbai. She has been in private practice since 29 years.

She is the only Indian to have served as President of all the three leading gynaecological, infertility and endoscopy organizations, The Federation of Obstetrics and Gynaecological Societies of India (FOGSI), an organization of 35000 gynaecologists from India, The Indian Society for Assisted Reproduction (ISAR) and the Indian Association of Gyanecologial Endoscopists (IAGE).

Experienced fertility nurse with management, business and quality management skills, and also has experience of working with Government and Health Boards to provide the best care to all who use fertility services within Scotland.

Human Fertilisation and Embryology Authority (HFEA)  member, appointed by the Secretary of State for Health and Social Care UK March 2022 – March 2028 

British Fertility Society (BFS) 

• Chair of Trustees as of January 2024
• Previously was secretary of British Fertility Society 1/4/2015 – 1/1/2024
• First nurse to become Honorary Secretary of the Society 2009-2012
• Training Committee 2000- 2009
• Executive Committee – Nurse Representative 2003-2009

Royal College of Nursing – Deputy Chair of Fertility Nurses Group 1998-2006. Currently working with the Fertility Nurses Forum on a project to deliver a national standards for senior fertility nurses.

Founder of Senior Infertility Nurses Group  – which provides peer support, guidance and encouragement to its members, promotes education and training for all fertility nurses working and caring for individuals seeking fertility treatment. Responsible for creating 18 teaching modules.

Founding member of the Scottish Infertility Counselling Group

Nurse Advisor on Education Committee of the International Federation of Fertility Societies (IFFS) working with Nurses worldwide to deliver a comprehensive training package for nurses. Have achieved this in Ghana and Nigeria and now working with Latin American nurses and exploring needs of nurses working in infertility in India

Trustee of Progress Educational Trust (11/8/2020  – current)

Worked on the National Infertility Group convened by Scottish Government 2011- 2022 which has produced national criteria to ensure equity of service throughout the country. The group was Chaired by the Chief Executive for NHS National Health Services. The reports were presented for consideration of the Scottish Government Ministers.

Also a member of three other groups convened by Scottish Government:

• National Fertility Preservation Service
• National Donor Services
• National Donor Criteria Group

Honorary Specialist Fellow, University of Aberdeen – 7 publications.

Specialized in reproductive endocrinology and infertility. Founder-chair of IFFS Next Generation Group. Immediate past president of World Association of Trainees in Obstetrics and Gynecology.

Dr. Yingying Qin serves as the President of Shandong Provincial Hospital, Shandong First Medical University. She is also a Professor and Chief Physician of Gynecological Endocrinology and Reproductive Medicine at Institute of Women, Children & Reproductive Health, Shandong University, China. She received her Ph.D. and M.D. in OB & GYN from Shandong University and has been a Visiting Scholar at Baylor College of Medicine, USA in 2006-2007. Her research focuses on Mechanism and intervention of female reproductive aging, with over 120 publications in N Engl J Med, Nat Med, Nat Aging, J Clin Invest, PNAS, etc. Dr. Qin has led multiple research projects funded by the Ministry of Science and Technology and National Natural Science Foundation of China. She has served as the Chair of the Chinese Special Interest Group (ChSIG) of American Society for Reproductive Medicine (ASRM) and Chinese Chair for Abstract Review at the 2019 World Congress of IFFS. In 2023 and 2024, she was recognized as one of the top 2% scientists in OB & GYN and Endocrinology & Metabolism.